Detalhe da pesquisa
1.
The life history of 21 breast cancers.
Cell
; 149(5): 994-1007, 2012 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22608083
2.
Mutational processes molding the genomes of 21 breast cancers.
Cell
; 149(5): 979-93, 2012 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22608084
3.
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.
Br J Cancer
; 128(12): 2283-2294, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076566
4.
Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study.
J Transl Med
; 21(1): 658, 2023 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37741974
5.
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
BMC Cancer
; 23(1): 738, 2023 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37563628
6.
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo.
Nature
; 543(7647): 714-718, 2017 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28329761
7.
Merged testing for colorectal cancer syndromes and re-evaluation of genetic variants improve diagnostic yield: Results from a nationwide prospective cohort.
Genes Chromosomes Cancer
; 61(10): 585-591, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35430768
8.
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach.
Hum Mutat
; 43(12): 1921-1944, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35979650
9.
High-definition spatial transcriptomics for in situ tissue profiling.
Nat Methods
; 16(10): 987-990, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31501547
10.
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.
Genet Med
; 24(1): 119-129, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34906479
11.
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.
Genet Epidemiol
; 44(5): 442-468, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32115800
12.
Molecular analyses of triple-negative breast cancer in the young and elderly.
Breast Cancer Res
; 23(1): 20, 2021 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33568222
13.
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer.
Breast Cancer Res
; 23(1): 26, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602273
14.
Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns.
Int J Cancer
; 148(4): 884-894, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32856720
15.
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Genet Med
; 23(9): 1726-1737, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34113011
16.
CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015-2020: implications for novel national recommendations.
Acta Oncol
; 60(7): 888-896, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945383
17.
Analysis of fusion transcripts indicates widespread deregulation of snoRNAs and their host genes in breast cancer.
Int J Cancer
; 146(12): 3343-3353, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32067223
18.
Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status.
Br J Cancer
; 123(11): 1608-1615, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32939053
19.
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
Genet Med
; 22(10): 1653-1666, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32665703
20.
Alternative splicing and ACMG-AMP-2015-based classification of PALB2 genetic variants: an ENIGMA report.
J Med Genet
; 56(7): 453-460, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30890586